Trial · NCT02277249
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
NCT02277249, Not applicable, Completed, University of California, Los Angeles; results first posted 2016-10-19
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion. Trials, record NCT02277249. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02277249
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
- NCT number
- NCT02277249
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- University of California, Los Angeles
- Conditions
- Abortion, Induced
- Interventions
- Digoxin (transvaginal administration), Digoxin (transabdominal administration)
- First posted
- 2014-10-28
- Last updated
- 2017-01-13
- Results first posted
- 2016-10-19
- Limitations and caveats
- There was crossover between treatment arms (4 subjects in the transvaginal group received transabdominal digoxin). This study is limited by its small sample size and attendant statistical power.
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patient Discomfort With Digoxin Injection (Pain Score) | At time of study (immediate) | Pain score (indicated by patient reporting pain level from 0 ("no hurt") to 5 ("hurts worst") at time of digoxin injection) |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Patient Discomfort With Digoxin Injection (Pain Score) | At time of study (immediate) | Units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patient Discomfort With Digoxin Injection (Pain Score) | Transvaginal Digoxin | 2.21 | Standard Deviation 1.33 | Units on a scale | |
| Patient Discomfort With Digoxin Injection (Pain Score) | Transabdominal Digoxin | 1.88 | Standard Deviation 1.54 | Units on a scale |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Transvaginal Digoxin | 30 | |
| Overall Study | STARTED | Transabdominal Digoxin | 30 | |
| Overall Study | COMPLETED | Transvaginal Digoxin | 30 | |
| Overall Study | COMPLETED | Transabdominal Digoxin | 30 | |
| Overall Study | NOT COMPLETED | Transvaginal Digoxin | 0 | |
| Overall Study | NOT COMPLETED | Transabdominal Digoxin | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Transvaginal Digoxin | ||
| Total, all-cause mortality | Transabdominal Digoxin | ||
| Total, other adverse events | Transvaginal Digoxin | 0 | 30 |
| Total, other adverse events | Transabdominal Digoxin | 0 | 30 |
| Total, serious adverse events | Transvaginal Digoxin | 0 | 30 |
| Total, serious adverse events | Transabdominal Digoxin | 0 | 30 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Transvaginal Digoxin vs Transabdominal Digoxin: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02277249
GET https://conductscience.org/api/trials/v1/NCT02277249/registered